Clinical Trials Update: Dec. 13, 2005
Peripheral Arterial Disease (PAD) Crohn's Disease Chronic Pain
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Peripheral Arterial Disease (PAD)
The primary purpose of this phase I clinical trial is to examine the safety of using a patient's own stem cells to stimulate new blood vessel growth in a leg with rest pain. To be eligible, patient must have unreconstructable vascular disease as determined by a vascular surgeon, be at least 21 years of age, and must have an ABI of less that 0.5 and a TBI of less than 0.4. Research site located in Indianapolis, Ind.
Study leaders are looking for men and women 18 years of age or older, with moderate-to-severe Crohn's disease as diagnosed by a medical doctor. Female participants cannot be pregnant or breast feeding. Enrolled patients will visit a physician's office for at least seven visits over a 5-month period. Research sites located throughout the United States.
This clinical research study will determine how well an investigational medication taken twice daily for fibromyalgia may relieve pain. Qualified participants with fibromyalgia must be at least 18. They will receive all study related exams and medication at no cost. Research sites located in Pennsylvania, Wisconsin, Missouri and North Carolina.
Copyright 2005 CenterWatch. All rights reserved.